Skip to content

Postoperative Opioid-Sparing Effect of a Pecto-Intercostal Fascial Block and Opioid-Free Anesthesia.

The Postoperative Opioid-Sparing Effect of an Intraoperative Pecto-Intercostal Fascial Block and Opioid-Free Anesthesia in Cardiac Surgery Patients: a Prospective Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04854577
Enrollment
64
Registered
2021-04-22
Start date
2021-05-31
Completion date
2022-09-30
Last updated
2021-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Anaesthesia, Opioid Free Anaesthesia

Keywords

Analgesics, Opioid, Anesthetics, Central Nervous System Depressants, Dexmedetomidine, Esketamine, Lidocaine, Ropivacaine, Pecto-Intercostal Fascial Plane Block, Physiological Effects of Drugs, Peripheral Nervous System Agents

Brief summary

The present study aims to assess the difference in postoperative opioid consumption between patients who intraoperatively receive a pecto-intercostal facial block combined with opioid-free anesthesia versus a traditional opioid-based regimen for cardiac surgery. The literature on opioid-free anesthesia for cardiac surgery is minimal and solely consists of case reports and retrospective studies. Nevertheless, these reports show the feasibility of opioid-free anesthesia. The purpose of this study is to assess the opioid-sparing effect and efficacy of combining an opioid-free anesthetic regimen with a pecto-intercostal fascial plane block (PIFB) in patients undergoing cardiac surgery. We hypothesize that opioid-free cardiac anesthesia with an intraoperative PIFB significantly reduces postoperative opioid consumption in comparison to a high-dose opioid intraoperative regimen.

Detailed description

Patients, aged 18 years or older, scheduled for coronary artery bypass graft surgery (CABG) with a complete midline sternotomy as surgical approach will be recruited for this study. Patients planned for this particular surgical procedure will be recruited and allocated to one of 2 groups: 1. Intervention group: Opioid-free anesthetic regimen with a pre-incisional pecto-intercostal fascial plane block (PIFB); 2. Control group: traditional opiate-based anesthetic regimen in which the dosage of the opioids is at the discretion of the attending anesthesiologist. Based on our power analysis, each group will consist of 64 patients.

Interventions

PROCEDUREOpioid Free Anesthesia

Patients will be administered a combination of a pre-incisional pecto-intercostal fascial plane block and a standardized opioid free anesthetic regimen consisting of dexmedetomidine, esketamine and lidocaine.

PROCEDURETraditional Anesthetic Regimen

Patients will be administered a traditional anesthetic regimen which is based on sufentanil dosage. The dosage is at the discretion of the attending anesthesiologist.

Sponsors

Algemeen Stedelijk Ziekenhuis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The patient will not be made aware of what has been administered. The outcome assessor will be blinded for the group allocation of patients. The investigator, as one of the care providers, nor the care providers can be blinded for the administered anesthetic regimen. The opioid free anesthetic regimen will be conducted by the same anesthesiologist.

Intervention model description

A randomized controlled, outcome assessor blinded study using two parallel study groups

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 years or older * Patients scheduled for coronary artery bypass graft surgery (CABG), which includes a complete midline sternotomy.

Exclusion criteria

* CABG surgery which did not include a complete midline sternotomy * Valve surgery * Aortic surgery * Emergency cardiac surgery * Known allergy for ropivacaine * Participation in another clinical trial * Known drug abuse * Preoperative cognitive dysfunction * Preoperative pain therapy with opioids or anticonvulsants 14 days before surgery * Patients unable to use Patient Controlled Analgesia (PCA) * Need of reintubation after initial extubation

Design outcomes

Primary

MeasureTime frameDescription
Postoperative morphine consumptionDay 2The total amount of morphine used postoperatively in the intensive care unit until discharge.

Secondary

MeasureTime frameDescription
Mean visual analogue score (VAS) pain score at restDay 2The mean VAS pain score at rest at 24 hours and 48 hours after extubation.
Mean visual analogue score (VAS) pain score whilst coughingDay 2The mean VAS pain score whilst coughing at 24 hours and 48 hours after extubation.
Time until extubationDay 0The time between ICU-arrival and extubation
Incidence of postoperative deliriumDay 2Incidence of postoperative delirium using the Confusion Assessment Method for ICU
Mean length of ICU stayDay 2The mean length of ICU stay, reported in hours.
Incidence of postoperative nausea and vomitingDay 2Incidence of postoperative nausea and vomiting (PONV)

Contacts

Primary ContactKoen Lapage, M.D.
koen.lapage@asz.be+32 53 764180

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026